Tate Financial Statements From 2010 to 2025
| TATYF Stock | USD 5.19 0.20 4.01% |
Check Tate Lyle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tate Lyle's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tate financial statements analysis is a perfect complement when working with Tate Lyle Valuation or Volatility modules.
Tate |
Tate Lyle plc OTC Stock Return On Equity Analysis
Tate Lyle's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tate Lyle Return On Equity | 0.0513 |
Most of Tate Lyle's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tate Lyle plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Tate Lyle plc has a Return On Equity of 0.0513. This is 98.06% lower than that of the Consumer Defensive sector and 100.97% lower than that of the Packaged Foods industry. The return on equity for all United States stocks is 116.55% lower than that of the firm.
Tate Lyle plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tate Lyle's current stock value. Our valuation model uses many indicators to compare Tate Lyle value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tate Lyle competition to find correlations between indicators driving Tate Lyle's intrinsic value. More Info.Tate Lyle plc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.82 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Tate Lyle plc is roughly 1.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tate Lyle's earnings, one of the primary drivers of an investment's value.About Tate Lyle Financial Statements
Tate Lyle stakeholders use historical fundamental indicators, such as Tate Lyle's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tate Lyle investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tate Lyle's assets and liabilities are reflected in the revenues and expenses on Tate Lyle's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tate Lyle plc. Please read more on our technical analysis and fundamental analysis pages.
Tate Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. Tate Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom. Tate Lyle is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Tate OTC Stock
Tate Lyle financial ratios help investors to determine whether Tate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tate with respect to the benefits of owning Tate Lyle security.